These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 113478)

  • 1. Mouse alloantibodies capable of blocking cytotoxic T-cell function. I. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 locus.
    Shinohara N; Sachs DH
    J Exp Med; 1979 Sep; 150(3):432-44. PubMed ID: 113478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse alloantibodies capable of blocking cytotoxic T cell function. II. Further study on the relationship between the blocking antibodies and the products of the Lyt-2 locus.
    Shinohara N; Hämmerling U; Sachs DH
    Eur J Immunol; 1980 Aug; 10(8):589-94. PubMed ID: 6967414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse alloantibodies capable of blocking cytotoxic T cell function. IV. Comparative analysis of the blocking effects of anti-Lyt-2 and anti-H-2 antibodies on allogeneic and PHA-mediated killing.
    Kojima M; Taniguchi M; Shinohara N
    Microbiol Immunol; 1983; 27(12):1093-105. PubMed ID: 6610091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse alloantibodies capable of blocking cytotoxic T cell function. III. Studies of the mechanism of blocking of CML by anti-Lyt-2 antibodies.
    Shinohara N; Taniguchi M; Kojima M
    J Immunol; 1981 Oct; 127(4):1575-8. PubMed ID: 6974198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse alloantibodies capable of blocking cytotoxic T cell function. V. The majority of I region-specific CTL are Lyt-2+ but are relatively resistant to anti-Lyt-2 blocking.
    Shinohara N; Kojima M
    J Immunol; 1984 Feb; 132(2):578-83. PubMed ID: 6197465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to murine cell surface antigens. I. Lyt-1.1.
    Hogarth PM; Potter TA; Cornell FN; McLachlan R; McKenzie IF
    J Immunol; 1980 Oct; 125(4):1618-24. PubMed ID: 6997382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking effect of lyt-2 antibodies on T cell functions.
    Hollander N; Pillemer E; Weissman IL
    J Exp Med; 1980 Sep; 152(3):674-87. PubMed ID: 6967947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of two monoclonal anti-Lyt-1 alloantibodies on lymphocyte distribution in vivo.
    Carroll AM; de Sousa M
    Immunology; 1984 Jun; 52(2):325-30. PubMed ID: 6234229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera.
    Nakayama E; Shiku H; Stockert E; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1977-81. PubMed ID: 88050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional relationships of Lyt-2 and Lyt-3 expression and T-cell cytotoxicity: a new model system.
    Palladino MA; Ranges GE; Oettgen HF; Old LJ
    Adv Exp Med Biol; 1985; 184():355-64. PubMed ID: 3875974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-2-linked genetic control of murine T-cell-mediated lympholysis to autologous cells modified with low concentrations of trinitrobenzene sulfonate.
    Shearer GM; Schmitt-Verhulst AM; Pettinelli CB; Miller MW; Gilheany PE
    J Exp Med; 1979 Jun; 149(6):1407-23. PubMed ID: 109569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyt phenotypes of primary cytotoxic T cells generated across the A and E region of the H-2 complex.
    Vidovic D; Juretic A; Nagy ZA; Klein J
    Eur J Immunol; 1981 Jun; 11(6):499-504. PubMed ID: 6973480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on cell surface antigens of mouse leukemic and normal lymphocytes. IV. Functional studies on mouse T lymphocyte subpopulations. B. Lyt phenotype of cytotoxic T lymphocytes and their precursors in B6-Lyt-1.1 mice.
    Kuśnierczyk P; Wysocka M; Kisielow P; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):111-6. PubMed ID: 312061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.
    Van Elven EH; Rolink AG; Veen FV; Gleichmann E
    J Exp Med; 1981 Jun; 153(6):1474-88. PubMed ID: 6454750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal anti-Lyt-2.2 antibody blocks lectin-dependent cellular cytotoxicity of H-2-negative target cells.
    Hünig T
    J Exp Med; 1984 Feb; 159(2):551-8. PubMed ID: 6363597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Qa2 subregion controls the expression of two antigens recognized by H-2-unrestricted cytotoxic T cells.
    Forman J; Trial J; Tonkonogy S; Flaherty L
    J Exp Med; 1982 Mar; 155(3):749-67. PubMed ID: 6174664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
    Flood PM
    J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.